Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 National Health and Nutrition Survey analysis.
Vaccine
; 36(52): 8094-8099, 2018 12 18.
Article
em En
| MEDLINE
| ID: mdl-30337174
ABSTRACT
To describe hepatitis A virus (HAV) seroprevalence and associated factors in adolescents (10-19â¯years) and young adults (20-25â¯years) in different Mexican regions, using 2012 National Health and Nutrition Survey data. A random selection of 1581 serum samples was analyzed. Weighted HAV seroprevalence with 95% confidence intervals (95%CI) and its association with sociodemographic factors were estimated. Mean weighted HAV seroprevalence was 69.3% (95%CI 64.8-73.4) overall, with 58.8% (95%CI 53.4-64.1) in adolescents and 83.0% (95%CI 75.3-88.7) in young adults. By age of 10, 46.7% (95%CI 33.9-60.0) were seropositive and by age of 15, 52.8% (95%CI 36.5-68.5), corresponding to intermediate endemicity nationally. Factors associated with HAV seropositivity (adjusted odds ratio, aOR) included lower socioeconomic status (SES) (aORâ¯=â¯4.09 for low and aORâ¯=â¯2.31 for medium versus high SES), older age (aORâ¯=â¯0.29 for adolescents versus young adults), living in the South (aORâ¯=â¯2.12 versus Central Mexico) or in rural areas (aORâ¯=â¯2.25 versus urban areas). Regional differences and increased seroprevalence of HAV in marginalized populations present an important public health issue, as a relatively large proportion of young adults are susceptible to infection. The burden of symptomatic disease must be addressed further to support specific programs of continued sanitation and education improvement, and the possibility of vaccination in more susceptible regions.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Hepatite A
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article